Broxyquinoline
Broxyquinoline is an antiprotozoal agent.
![]()  | |
![]()  | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names | 
| ATC code | |
| Identifiers | |
  | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.007.563 | 
| Chemical and physical data | |
| Formula | C9H5Br2NO | 
| Molar mass | 302.953 g·mol−1 | 
| 3D model (JSmol) | |
  | |
  | |
|   | |
An association with exercise intolerance has been reported.[1]
References
    
- Swain R, Bapna JS (January 1986). "Impairment of exercise tolerance due to broxyquinoline-brobenzoxaldine combination". Human Toxicology. 5 (1): 63–4. doi:10.1177/096032718600500115. PMID 3081430.
 
    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

